Cargando…
Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy
OBJECTIVE: Anti IgE treatment with omalizumab is efficacious in the treatment of patients suffering from allergic asthma, improving asthma control and improving quality of life. Furthermore, this approach could be beneficial for patients with concomitant atopic dermatitis. We assessed quality of lif...
Autores principales: | Velling, P, Skowasch, D, Pabst, S, Jansen, E, Tuleta, I, Grohé, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352146/ https://www.ncbi.nlm.nih.gov/pubmed/22024441 http://dx.doi.org/10.1186/2047-783X-16-9-407 |
Ejemplares similares
-
The dynamics of the manifestations of atopic dermatitis in severe persistent uncontrolled asthma children with omalizumab therapy
por: Vishneva, Elena, et al.
Publicado: (2015) -
The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma
por: Zheng, Tao, et al.
Publicado: (2011) -
The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma
por: Bantz, Selene K., et al.
Publicado: (2014) -
Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018) -
Omalizumab for severe allergic asthma: a life changing drug?
por: Mesonjesi, Eris, et al.
Publicado: (2015)